Drugs · acquisition-cost intelligence
Albuterol Sulfate Inhalation Solution
Albuterol Sulfate· ingredient albuterolSelective beta-2-adrenoreceptor agonists· ALBUTEROL SULFATE 1.25 mg/3mL; ALBUTEROL SULFATE .63 mg/3mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.22472
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other albuterol products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Albuterol Sulfate | $0.03508 | −$0.18960 |
| albuterol sulfate | $0.06535 | −$0.15940 |
| Ipratropium Bromide and Albuterol Sulfate | $0.08739 | −$0.13730 |
| Albuterol | $0.32659 | +$0.10190 |
| Albuterol Sulfate Inhalation Solution, 0.5% | $0.51281 | +$0.28810 |
| Albuterol Sulfate HFA | $1.65 | +$1.43 |
| Albuterol | $1.82 | +$1.60 |
| albuterol sulfate | $2.14 | +$1.92 |
Medicare Part D coverage · CY2026
On 327 plan formularies · typical tier 2
Prior auth 100% · Step therapy 0% · Quantity limit 10% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.